VABIOTECH, one of Vietnam’s leading pharmaceutical companies, and the Russian Direct Investment Fund (RDIF) on July 21 announced the production of a test batch of the Russian Sputnik V vaccine against the coronavirus in Vietnam.
According to VABIOTECH, the made-in-Vietnam Sputnik V vaccine will be used in the national immunisation programme after the technology transfer is completed and it goes through quality control by Gamaleya Center, the Russian research institute that develops the Sputnik V vaccine.
To date, Sputnik V has been registered in 68 countries with a total population of over 3.7 billion, which is nearly half of the global population. The data obtained by regulators of a number of countries during the vaccination of people in Mexico, Argentina, Serbia, Bahrain, Hungary, the UAE, and others, demonstrates that Sputnik V is one of the safest and most effective vaccines against the coronavirus.
Summary content from
"Tin tức 1" shows summary content only. Please view full content from Vietnamplus at: https://en.vietnamplus.vn/vietnam-produces-test-batch-of-sputnik-v-vaccine/205118.vnp